FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers,
get FHACT®.
Webinar series.

LEARN MORE >

FHACT® is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT® is the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

26 Feb 15

Cancer Genetics to Report Fourth Quarter and Fiscal Year 2014 Financial Results on Thursday, March 12 (read more...)

- RUTHERFORD, N.J., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics, (read more...)
24 Feb 15

Cancer Genetics Inc to Present New Data on Identification of Genomic Changes That Predict Both Metastasis and Site of Metastasis in Kidney Cancer at the 2015 ASCO Genitourinary Cancers Symposium (read more...)

- > CGI's genomic signature, developed in a research collaboration with Memorial Sloan-Kettering, predicts metastasis for clear-cell renal cell (read more...)

Events

05 May 15

International Society for Biological and Environmental Repositories

21 Mar 15

United States & Canadian Academy of Pathology

12 Mar 15

4th Quarter and Fiscal Year 2014 Conference Call

- Dial-In InformationU.S. Toll-Free: 877-407-4018International: 201-689-8471Conference ID: 13601913 Replay InformationU.S. Toll-Free: 877-870-(read more...)
Clinicians
Patients